A four-year randomized trial in Belo Horizonte, Brazil, found that children in areas where Wolbachia-carrying mosquitoes were released had 68.6% fewer arbovirus infections overall than children in comparison areas, including during Brazil's record dengue outbreak in 2024.
The EVITA study followed 5,757 children ages 6 to 11 from 2020 through 2024 in 58 school-based areas. Half of the areas were assigned to mosquito releases alongside usual control measures, and half to usual measures alone. Researchers released the Wolbachia-carrying Aedes aegypti mosquitoes between January 2021 and May 2022.
They tested annual blood samples for signs of dengue, Zika and chikungunya infection. Researchers reported that the approach was 68.5% effective against dengue and 73.3% effective against chikungunya. They said there were too few Zika infections to determine whether the approach reduced that virus specifically.
Wolbachia is a naturally occurring bacterium that can limit mosquitoes' ability to spread certain viruses. Female mosquitoes pass the bacterium to their offspring, helping it remain in local populations. The results were presented at a scientific meeting on November 21.
They have not yet been reviewed by other experts or appeared in a journal, so the findings remain preliminary.